By Maddie Sorenson Integra Lifesciences Holdings Corp (NASDAQ:IART)‘s stock had its “buy” rating reaffirmed by investment analysts at Oppenheimer in a research note issued on Wednesday, Analyst Ratings Net reports. Shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) traded down 0.23% during mid-day trading on Wednesday, reaching $68.44. 49,298 shares of the company’s stock traded hands. The stock’s […]